TrialJNCI cancer spectrum2021

Outcomes of Hormone-Receptor Positive, HER2-Negative Breast Cancers by Race and Tumor Biological Features.

Halei C Benefield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.